No jab, no job: COVID-19 vaccine could be mandatory for employees
Here’s what SMEs think
COVID-19 vaccine - page 2
COVID-19 vaccine frontrunners: who are they (UPD)
Who are the vaccine frontrunners and how promising are their developed prototypes – that’s what we’re going to discover
Should you invest in drug companies?
Nina Bobro PaySpace Magazine Analyst Companies dealing with medicine production have always been attractive to any investor’s portfolio. After all, illnesses and diseases pose a constant threat to humanity. At the same time, the healthcare industry is rapidly evolving, bringing us longevity unimaginable in the early twentieth century. Moreover, the development of new biotechnologies […]
Vaccination doesn’t mean the end of the pandemic: survey
The survey sheds light on the opinions of 1,000 Americans
Countries leading in COVID-19 vaccine trials unveiled
Let’s take a look at these frontrunners
Two Nordic countries will issue digital vaccine certificates
That will be quick and easy to prove a completed vaccination
India is expected to provide 700M doses of Covaxin in 2021
Covaxin Phase III trial is anticipated by March 2021
Moderna on track to deliver additional 100M doses to US: here’s when
The company confirms discussions with the US Government for additional COVID-19 vaccine’s doses
Israel named world’s first country to control COVID-19’s pandemic
On December 27, Israel entered a third national lockdown, due to the recent detection of 2 new highly COVID-19 strains
COVID-19 vaccine rollout drives UK businesses’ growth expectations
8 out of 14 UK sectors outperformed their international counterparts in December
Hackers leaked stolen Pfizer COVID-19 vaccine data
EMA is responsible for reviewing and approving COVID-19 vaccines
COVID-19 vaccine rollout will revive global economies: research
The pandemic has created serious challenges such as youth unemployment, rising poverty, and income inequality
UK to pilot digital COVID-19 immunity and vaccination passports
The companies aim to complete two trials by March 2021
Pfizer-BioNTech’s COVID-19 vaccine to generate $30B in sales: forecast
However, there are several challenges
US market value for COVID-19 tests to exceed $31B this year
Currently, testing centers in the US have become overburdened by the surge in COVID-19 cases
UK SMEs revealed their thoughts regarding COVID-19 vaccine
More than 500 small and medium-sized enterprises have been surveyed to find out their predictions for 2021
Breaking News
© 2024 PAY SPACE, LLC
03148 Ukraine, Kyiv, 2A P.Kurinoho str.